Detection of Variants With Reduced Baloxavir Marboxil Susceptibility After Treatment of Children With Influenza A During the 2018-2019 Influenza Season

被引:27
作者
Sato, Masatoki [1 ]
Takashita, Emi [2 ]
Katayose, Masahiko [3 ]
Nemoto, Kenji [4 ]
Sakai, Nobuko [5 ]
Hashimoto, Koichi [1 ]
Hosoya, Mitsuaki [1 ]
机构
[1] Fukushima Med Univ, Dept Pediat, 1 Hikarigaoka, Fukushima 9601295, Japan
[2] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan
[3] Nanohana Kids Clin, Soma, Japan
[4] Nemoto Kids Clin, Shirakawa, Japan
[5] Jin Kids Clin, Koriyama, Fukushima, Japan
基金
日本学术振兴会;
关键词
antiviraltherapy; baloxavir; influenza; oseltamivir; resistance; ADULTS;
D O I
10.1093/infdis/jiaa061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During the 2018-2019 influenza seasons, we detected reduced baloxavir marboxil (baloxavir) susceptible variants with I38S or I38T amino acid substitutions on the PA subunit of influenza virus ribonucleic acid polymerase in 7 of 18 baloxavi-treated children and found that virus titer rebounded in some of these children with variants. We also found fever durations to be similar between patients with or without the variants, but the patients with variants shed the virus 3 days longer and took longer to improve clinical symptoms than those without variants. The emergence of these variants should be monitored during future influenza seasons.
引用
收藏
页码:121 / 125
页数:5
相关论文
共 50 条
  • [21] Epidemiology of Influenza Viruses and Viruses Causing Influenza-Like Illness in Children Under 14 Years Old in the 2018-2019 Epidemic Season in Poland
    Kondratiuk, Katarzyna
    Hallmann, Ewelina
    Luniewska, Katarzyna
    Szymanski, Karol
    Brydak, Lidia
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [22] ETIOLOGY OF INFLUENZA-LIKE ILLNESSES IN THE POPULATION OF NOVOSIBIRSK CITY IN THE 2018-2019 EPIDEMIC SEASON
    Kurskaya, O. G.
    Anoshina, A., V
    Leonova, N., V
    Simkina, O. A.
    Komissarova, T., V
    Esikova, E. Yu
    Pozdnyakova, L. L.
    Sobolev, I. A.
    Prokopyeva, E. A.
    Kazachkova, E. A.
    Danilenko, D. M.
    Komissarov, A. B.
    Stolyarov, K. A.
    Fadeev, A., V
    Sominina, A. A.
    Sharshov, K. A.
    Yu, Alekseev A.
    Shestopalov, A. M.
    Murashkina, T. A.
    INFEKTSIYA I IMMUNITET, 2021, 11 (04): : 723 - 736
  • [23] Evaluating impact of school outreach vaccination programme in Hong Kong influenza season 2018-2019
    Lau, Yu Lung
    Wong, Wilfred Hing Sang
    Hattangdi-Haridas, Sonal R.
    Chow, Chun Bong
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (04) : 823 - 826
  • [24] Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018-2019 United States Influenza Season
    Boikos, Constantina
    Imran, Mahrukh
    Van Hung Nguyen
    Ducruet, Thierry
    Sylvester, Gregg C.
    Mansi, James A.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07):
  • [25] A cost-effectiveness analysis of reduced viral transmission with baloxavir marboxil versus oseltamivir or no treatment for seasonal and pandemic influenza management in the United Kingdom
    Kommandantvold, Svenn Alexander
    Lemenuel-Diot, Annabelle
    Skedgel, Chris
    Pitman, Richard
    Rouse, Peter
    Zaraket, Hassan
    Zhou, Hao
    Zumofen, Marie-Helene Blanchet
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024, 24 (08) : 953 - 966
  • [26] Adult influenza A (H3N2) with reduced susceptibility to baloxavir or peramivir cured after switching anti-influenza agents
    Seki, Masafumi
    Sakai-Tagawa, Yuko
    Yasuhara, Atsuhiro
    Watanabe, Yuji
    IDCASES, 2019, 18
  • [27] Predominance of a Drifted Influenza A (H3N2) Clade and Its Association with Age-Specific Influenza Vaccine Effectiveness Variations, Influenza Season 2018-2019
    Glatman-Freedman, Aharona
    Pando, Rakefet
    Sefty, Hanna
    Omer, Itay
    Rosenberg, Alina
    Drori, Yaron
    Nemet, Ital
    Mendelson, Ella
    Keinan-Boker, Lital
    Mandelboim, Michal
    VACCINES, 2020, 8 (01)
  • [28] Knowledge, attitudes and uptake related to influenza vaccine among healthcare workers during the 2018–2019 influenza season in Tunisia
    Ines Cherif
    Ghassen Kharroubi
    Leila Bouabid
    Adel Gharbi
    Aicha Boukthir
    Nissaf Ben Alaya
    Afif Ben Salah
    Jihene Bettaieb
    BMC Public Health, 21
  • [29] Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season
    Flannery, Brendan
    Kondor, Rebecca J. Garten
    Chung, Jessie R.
    Gaglani, Manjusha
    Reis, Michael
    Zimmerman, Richard K.
    Nowalk, Mary Patricia
    Jackson, Michael L.
    Jackson, Lisa A.
    Monto, Arnold S.
    Martin, Emily T.
    Belongia, Edward A.
    McLean, Huong Q.
    Kim, Sara S.
    Blanton, Lenee
    Kniss, Krista
    Budd, Alicia P.
    Brammer, Lynnette
    Stark, Thomas J.
    Barnes, John R.
    Wentworth, David E.
    Fry, Alicia M.
    Patel, Manish
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (01) : 8 - 15
  • [30] Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018-2019 Influenza Season in the United States
    Boikos, Constantina
    Fischer, Lauren
    O'Brien, Dan
    Vasey, Joe
    Sylvester, Gregg C.
    Mansi, James A.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (03) : E692 - E698